Alternative 5' exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini.
Among the alternative pre-mRNA splicing events that characterize protein 4.1R gene expression, one involving exon 2' plays a critical role in regulating translation initiation and N-terminal protein structure. Exon 2' encompasses translation initiation site AUG1 and is located between alternative splice acceptor sites at the 5' end of exon 2; its inclusion or exclusion from mature 4.1R mRNA regulates expression of longer or shorter isoforms of 4.1R protein, respectively. The current study reports unexpected complexity in the 5' region of the 4.1R gene that directly affects alternative splicing of exon 2'. Identified far upstream of exon 2 in both mouse and human genomes were 3 mutually exclusive alternative 5' exons, designated 1A, 1B, and 1C; all 3 are associated with strong transcriptional promoters in the flanking genomic sequence. Importantly, exons 1A and 1B splice differentially with respect to exon 2', generating transcripts with different 5' ends and distinct N-terminal protein coding capacity. Exon 1A-type transcripts splice so as to exclude exon 2' and therefore utilize the downstream AUG2 for translation of 80-kDa 4.1R protein, whereas exon 1B transcripts include exon 2' and initiate at AUG1 to synthesize 135-kDa isoforms. RNA blot analyses revealed that 1A transcripts increase in abundance in late erythroblasts, consistent with the previously demonstrated up-regulation of 80-kDa 4.1R during terminal erythroid differentiation. Together, these results suggest that synthesis of structurally distinct 4.1R protein isoforms in various cell types is regulated by a novel mechanism requiring coordination between upstream transcription initiation events and downstream alternative splicing events.
Parra
Marilyn K
MK
Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA 94720, USA.
Gee
Sherry L
SL
Koury
Mark J
MJ
Mohandas
Narla
N
Conboy
John G
JG
D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D015152:Blotting, Northern; D016384:Consensus Sequence; D003598:Cytoskeletal Proteins; D017931:DNA Primers; D004900:Erythroblasts / Q000378:metabolism; D005091:Exons; D005784:Gene Amplification; D006801:Humans; D008565:Membrane Proteins; D051379:Mice; D008969:Molecular Sequence Data; D009479:Neuropeptides; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000235:genetics; D011506:Proteins / Q000235:genetics*; D016415:Sequence Alignment; D014158:Transcription, Genetic
D003598:Cytoskeletal Proteins; D017931:DNA Primers; D008565:Membrane Proteins; D009479:Neuropeptides; D020033:Protein Isoforms; D011506:Proteins; C028841:erythrocyte membrane band 4.1 protein; C120557:erythrocyte membrane protein band 4.1-like 1